Effects of long-term alendronate treatment on bone mineralisation, resorption parameters and biomechanics of single human vertebral trabeculae
Due to their well-established fracture risk reduction, bisphosphonates are the most frequently used therapeutic agent to treat osteoporosis. Bisphosphonates reduce fracture risk by suppressing bone resorption, but the lower bone turnover could have a negative impact on bone quality at the tissue lev...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
AO Research Institute Davos
2014-09-01
|
Series: | European Cells & Materials |
Subjects: | |
Online Access: | http://www.ecmjournal.org/journal/papers/vol028/pdf/v028a12.pdf |